Tirzepatide 30

Tirzepatide 30 — 30mg Research Peptide Tirzepatide 30 contains 30mg of Tirzepatide, a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This higher-concentration formulation provides researchers with a more concentrated option for advanced research protocols. With demonstrated efficacy across the SURPASS and SURMOUNT clinical trial programs, Tirzepatide has emerged as a leading research compound in the study of metabolic pathways, incretin biology, and energy balance regulation. Key Research Areas: - Dual incretin receptor agonism (GIP/GLP-1) - Advanced metabolic pathway research - Weight management research models - Insulin sensitivity studies - Lipid metabolism investigations - Cardiovascular metabolic research Composition per vial: Tirzepatide — 30mg Storage: Store at -20°C for long-term stability. Reconstituted solutions should be stored at 2-8°C. Handling: Follow appropriate laboratory handling procedures. Disclaimer: This product is intended for research purposes only. Not for human consumption.